Supplementary Table 6 from Colorectal Cancer Recurrence Prediction Using a Tissue-Free Epigenomic Minimal Residual Disease Assay
Nakamura Y., Tsukada Y., Matsuhashi N., Murano T., Shiozawa M., Takahashi Y., Oki E., Goto M., Kagawa Y., Kanazawa A., Ohta T., Ouchi A., Bando H., Uchigata H., Notake C., Ikematsu H., Yoshino T.
<p>Supplementary Table 6. Risk of recurrence based on ctDNA detection following adjuvant chemotherapy in patients with stage II or higher CRC. Tables to accompany Figure 5A-B.</p>